The goal of this clinical trial es to learn about the short term effects of intravitreal dexamethasone implant (IDI) in patients with refractory diabetic macular edema. The main question it aims to answer is: How fast does the diminishing in central retinal thickness has statistical significance after IDI in patients with refractory diabetic macular edema? Patients will be evaluated by OCT before and after the implant.
Patients were evaluated at baseline, 2 hours, 3 hours, 24 hours, 1 week and 1 month post IDI
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
15
Intravitreal implant of dexamethasone 0.7 mg with previous topic anesthesia and iodine drops
Asociacion Para Evitar la Ceguera en Mexico
Mexico City, Coyoacan, Mexico
Change in central retinal thickness
Difference among the baseline and the posterior measurements of the CRT with OCT
Time frame: Prospective: from baseline to 2 hours, 3 hours, 24 hours, 1 week and 1 month post IDI
Change in Best Corrected Visual Acuity
Measurement of Best Corrected Visual Acuity before and after IDI
Time frame: Prospective: from baseline to 1 month post IDI
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.